(MedPage Today) — The meteoric rise of GLP-1 drugs for weight loss has raised concerns about potential malnutrition and even the comeback of scurvy. (The Hill)
An $80-per-month produce prescription subsidy failed to improve cardiometabolic health…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119918
Author :
Publish date : 2026-02-17 19:46:00
Copyright for syndicated content belongs to the linked Source.
